Medicine – Copper Metabolism and Wilson Disease

Wilson disease is an inherited disorder of copper metabolism in which the body cannot excrete copper normally into bile. Copper therefore progressively accumulates, particularly in the liver, brain, cornea and other tissues, producing hepatic, neurological, psychiatric and systemic manifestations.

The disorder is inherited in an:

Autosomal recessive – AR pattern.

1. Normal Copper Metabolism

Copper is an essential trace element obtained from the diet. After intestinal absorption, copper is transported to the:

Liver.

The liver has a central role in incorporating copper into proteins and eliminating excess copper from the body.

2. Ceruloplasmin

The original notes state that copper normally binds to a globulin to form:

Ceruloplasmin.

This is broadly correct, although the mechanism can be described more precisely.

Ceruloplasmin is a copper-containing plasma protein synthesised in the:

Liver.

Most circulating copper is carried bound to:

Ceruloplasmin.

3. Copper Excretion

The original notes correctly state that copper is predominantly excreted through:

Bile.

The liver secretes excess copper into bile, which passes into the intestine and is eventually eliminated in:

Faeces.

Urinary copper excretion is normally relatively small.

Therefore:

BILE IS THE MAJOR ROUTE OF COPPER EXCRETION.

4. Wilson Disease

Wilson disease results from pathogenic variants in the:

ATP7B gene.

ATP7B is located on:

Chromosome 13.

It encodes a copper-transporting ATPase that is particularly important in hepatocytes.

5. Inheritance

Wilson disease is:

Autosomal recessive.

Therefore an affected individual usually inherits a pathogenic ATP7B variant from:

Each parent.

Siblings of an affected patient may therefore require appropriate screening.

6. ATP7B Function

ATP7B normally has two particularly important functions:

It helps incorporate copper into ceruloplasmin.

and

It facilitates excretion of excess copper into bile.

When ATP7B function is defective, both processes are impaired.

7. Pathophysiology

The basic mechanism is:

ATP7B defect

↓

↓ biliary copper excretion

↓

Copper accumulates in hepatocytes

↓

Hepatic injury

↓

Copper eventually enters the circulation and deposits in other organs

↓

Brain + cornea + kidneys + joints + other tissues affected.

8. Important Correction About Ceruloplasmin

The original statement:

“Abnormality of ceruloplasmin formation and biliary excretion”

is broadly useful, but Wilson disease is fundamentally caused by:

Defective ATP7B-mediated copper transport.

The major problem responsible for copper overload is:

Impaired biliary copper excretion.

Ceruloplasmin is typically low because copper is not incorporated normally into apoceruloplasmin, which is then degraded more rapidly.

9. Liver Disease

The liver is often one of the first organs affected.

Wilson disease can produce a wide spectrum of hepatic disease, including:

Asymptomatic elevation of liver enzymes.

Acute hepatitis.

Chronic hepatitis.

Fibrosis.

Cirrhosis.

Acute liver failure.

Therefore Wilson disease should be considered particularly in a:

Young person with otherwise unexplained liver disease.

10. Acute Liver Failure

Wilson disease can occasionally present with:

Fulminant/acute liver failure.

This may be accompanied by:

Coombs-negative haemolytic anaemia.

Jaundice.

Coagulopathy.

Renal dysfunction.

This is a medical emergency.

11. Kayser–Fleischer Rings

The original notes correctly identify:

Kayser–Fleischer rings – KF rings

as a classic feature.

They result from copper deposition in:

Descemet membrane of the cornea.

12. Appearance of Kayser–Fleischer Rings

KF rings appear as:

Brownish, golden or greenish-brown rings

around the peripheral cornea.

They are best detected using:

Slit-lamp examination.

13. Significance of Kayser–Fleischer Rings

KF rings are particularly common in patients with:

Neurological Wilson disease.

However, an important point is:

ABSENCE OF KF RINGS DOES NOT EXCLUDE WILSON DISEASE.

They may be absent, particularly in patients presenting predominantly with hepatic disease.

14. Neurological Manifestations

Copper deposition in the brain, particularly the:

Basal ganglia,

can produce numerous neurological abnormalities.

Possible features include:

Tremor.

Dysarthria.

Dystonia.

Parkinsonian features.

Rigidity.

Bradykinesia.

Ataxia or impaired coordination.

Abnormal involuntary movements.

15. Tremor

A classic neurological manifestation is tremor.

A characteristic but not universal description is:

Wing-beating tremor.

This is a coarse proximal tremor that may become prominent when the arms are held out.

16. Psychiatric Manifestations

Psychiatric and behavioural changes are also important.

Patients may develop:

Personality change.

Irritability.

Depression.

Anxiety.

Behavioural deterioration.

Psychosis in some cases.

Declining school or work performance.

Therefore Wilson disease can initially appear to be a primary psychiatric or neurological disorder.

17. Arthropathy

The original notes correctly include:

Arthropathy.

Joint manifestations may include:

Joint pain.

Premature degenerative changes.

Arthritis-like symptoms.

Large joints such as the knees may be affected.

18. Haemolytic Anaemia

Wilson disease can cause:

Coombs-negative intravascular haemolytic anaemia.

This is particularly important during acute hepatic deterioration.

When damaged hepatocytes suddenly release large amounts of copper into the circulation, free copper can damage:

Red-cell membranes.

This produces:

Haemolysis.

19. Haemolysis – Note Form

Hepatocyte injury

↓

Sudden release of copper

↓

Free circulating copper rises

↓

RBC membrane injury

↓

Coombs-negative intravascular haemolysis.

Therefore:

YOUNG PATIENT + LIVER FAILURE + COOMBS-NEGATIVE HAEMOLYSIS → THINK WILSON DISEASE.

20. Other Manifestations

Copper accumulation can affect other organs.

Possible manifestations include:

Renal tubular dysfunction.

Nephrolithiasis.

Skeletal abnormalities.

Cardiac involvement, although less common.

The clinical presentation is highly variable.

21. Diagnosis of Wilson Disease

The diagnosis should not usually depend on one test alone.

Assessment combines:

Serum ceruloplasmin.

Urinary copper excretion.

Slit-lamp examination for KF rings.

Serum copper assessment in appropriate contexts.

Liver copper measurement when needed.

ATP7B genetic testing.

22. Serum Ceruloplasmin

The original notes correctly state:

Ceruloplasmin is usually low.

This is an important clue to Wilson disease.

However:

Low ceruloplasmin alone does not establish the diagnosis.

It can also occur in other conditions.

Conversely, some patients with Wilson disease may have ceruloplasmin values that are not markedly reduced.

23. Serum Copper – Important Paradox

A potentially confusing feature is that:

Total serum copper may be low

because most circulating copper is normally bound to ceruloplasmin, and ceruloplasmin is reduced.

However, the biologically important:

Non-ceruloplasmin-bound copper

may be increased.

Therefore:

LOW TOTAL SERUM COPPER DOES NOT EXCLUDE COPPER OVERLOAD IN WILSON DISEASE.

The problem is abnormal tissue accumulation and increased toxic circulating copper, not simply the total serum copper concentration.

24. Urinary Copper

The original notes correctly include:

High urinary copper.

Twenty-four-hour urinary copper excretion is typically increased because excess non-ceruloplasmin-bound copper becomes available for renal excretion.

Therefore:

WILSON DISEASE → ↑ URINARY COPPER.

25. Liver Biopsy

The original notes include:

Liver biopsy.

When required, hepatic copper concentration can be measured from biopsy tissue.

A markedly elevated hepatic copper concentration strongly supports:

Wilson disease.

However, liver biopsy is not necessary in every patient if the diagnosis can be established through biochemical, ophthalmological and genetic findings.

26. Genetic Testing

Modern evaluation may include:

ATP7B genetic testing.

Identification of pathogenic variants on both alleles can strongly support or establish the diagnosis in the appropriate clinical context.

Genetic testing is also useful for:

Family screening.

27. Brain Imaging

In patients with neurological disease, MRI may demonstrate abnormalities involving structures such as the:

Basal ganglia.

However, MRI findings are supportive rather than diagnostic by themselves.

28. Treatment

Wilson disease requires:

Lifelong management.

Treatment aims to reduce toxic copper accumulation and prevent further deposition.

Major approaches include:

Copper chelation.

Reduction of intestinal copper absorption.

Liver transplantation in selected severe disease.

29. Penicillamine

The original notes correctly identify:

D-penicillamine

as a copper-chelating drug.

It binds copper and promotes its elimination, particularly through:

Urine.

Therefore:

PENICILLAMINE + COPPER → CHELATED COPPER → ↑ URINARY EXCRETION.

30. Adverse Effects of Penicillamine

Penicillamine can cause significant adverse effects, including:

Bone-marrow suppression.

Proteinuria and renal toxicity.

Skin reactions.

Autoimmune complications.

Neurological symptoms can sometimes worsen after treatment initiation, so specialist monitoring is important.

31. Trientine

An important alternative copper chelator is:

Trientine.

It can be used as an alternative to penicillamine in appropriate patients and also increases:

Urinary copper excretion.

Modern Wilson disease management is therefore not limited to penicillamine alone.

32. Zinc Therapy

Zinc salts provide another treatment strategy.

Zinc reduces intestinal copper absorption by inducing intestinal:

Metallothionein.

Metallothionein binds copper within enterocytes.

The copper is then lost when the intestinal cells are shed.

Therefore:

ZINC → ↓ INTESTINAL COPPER ABSORPTION.

Zinc may be used in selected patients, including maintenance therapy depending on the clinical situation.

33. Liver Transplantation

The original notes correctly include:

Liver transplantation.

It is particularly important in:

Acute liver failure due to Wilson disease

and selected patients with:

Decompensated end-stage liver disease.

34. Why Liver Transplantation Is Particularly Effective

The liver contains the major defect in ATP7B-mediated copper handling.

Replacing the liver therefore restores:

Normal hepatic copper metabolism and biliary copper excretion.

Thus transplantation can effectively correct the underlying metabolic defect.

35. Dietary Considerations

During treatment, patients may be advised to avoid excessive intake of particularly copper-rich foods, especially early in therapy.

Examples can include:

Liver and organ meats.

Shellfish.

Some nuts and chocolate.

However, dietary restriction alone is:

Not adequate treatment for established Wilson disease.

36. Wilson Disease – Note Form

Inheritance:

Autosomal recessive.

Gene:

ATP7B.

Chromosome 13.

Normal physiology:

Copper transported to liver.

↓

Copper incorporated into ceruloplasmin.

↓

Excess copper excreted in bile.

Wilson disease:

ATP7B defect.

↓

↓ Copper incorporation into ceruloplasmin.

• ●

↓ Biliary copper excretion.

↓

Copper accumulation.

↓

Liver + brain + cornea + other organs.

37. Clinical Features – Note Form

Liver:

Acute hepatitis.

Chronic hepatitis.

Cirrhosis.

Acute liver failure.

Eye:

Kayser–Fleischer rings.

Copper deposited in Descemet membrane.

CNS:

Tremor.

Dystonia.

Dysarthria.

Parkinsonian features.

Movement abnormalities.

Psychiatric:

Personality change.

Depression.

Behavioural disturbance.

Psychosis in some cases.

Joints:

Arthropathy.

Blood:

Coombs-negative haemolytic anaemia.

38. Diagnosis – Note Form

Ceruloplasmin:

Usually ↓.

24-hour urinary copper:

↑.

Kayser–Fleischer rings:

Detected by slit lamp.

Liver copper:

↑ when measured.

ATP7B genetic testing:

Supports/confirms diagnosis in appropriate circumstances.

39. Treatment – Note Form

Penicillamine:

Copper chelator.

↓

↑ urinary copper excretion.

Trientine:

Alternative copper chelator.

↓

↑ urinary copper excretion.

Zinc:

↓ intestinal copper absorption.

Liver transplantation:

Acute liver failure or selected severe/decompensated liver disease.

↓

Corrects hepatic metabolic defect.

40. Important Corrections to the Original Notes

The original statement:

“Copper usually binds to globulin to form ceruloplasmin”

is better expressed as:

CERULOPLASMIN IS A COPPER-CONTAINING PROTEIN SYNTHESISED BY THE LIVER AND CARRIES MOST CIRCULATING COPPER.

The original statement:

“Abnormality of ceruloplasmin formation and biliary excretion”

is broadly correct, but the fundamental defect is:

ATP7B MUTATION → IMPAIRED COPPER INCORPORATION INTO CERULOPLASMIN + IMPAIRED BILIARY COPPER EXCRETION.

The impaired biliary excretion is particularly important for:

Progressive tissue copper accumulation.

Low ceruloplasmin is an important diagnostic clue but is:

Not diagnostic by itself.

High urinary copper is an important feature.

Liver biopsy can measure hepatic copper but is:

Not mandatory in every patient.

Treatment is broader than:

“Penicillamine + liver transplantation.”

Modern management may include:

PENICILLAMINE, TRIENTINE, ZINC, AND LIVER TRANSPLANTATION WHEN INDICATED.

Key Clinical Pattern

For rapid recall:

WILSON DISEASE = AR ATP7B DEFECT ON CHROMOSOME 13.

ATP7B DEFECT → ↓ BILIARY COPPER EXCRETION → COPPER ACCUMULATION.

Think:

LIVER → HEPATITIS / CIRRHOSIS / ACUTE LIVER FAILURE.

EYE → KAYSER–FLEISCHER RINGS.

BRAIN → TREMOR / DYSTONIA / PARKINSONISM / PSYCHIATRIC CHANGE.

JOINTS → ARTHROPATHY.

BLOOD → COOMBS-NEGATIVE HAEMOLYTIC ANAEMIA.

For diagnosis:

↓ CERULOPLASMIN + ↑ URINARY COPPER + KF RINGS ± ↑ HEPATIC COPPER + ATP7B TESTING.

For treatment:

CHELATE COPPER WITH PENICILLAMINE OR TRIENTINE → REDUCE ABSORPTION WITH ZINC → TRANSPLANT FOR SEVERE LIVER FAILURE.